Reshma S. Baliga

2.0k total citations
32 papers, 1.4k citations indexed

About

Reshma S. Baliga is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Reshma S. Baliga has authored 32 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Cardiology and Cardiovascular Medicine, 15 papers in Pulmonary and Respiratory Medicine and 10 papers in Molecular Biology. Recurrent topics in Reshma S. Baliga's work include Pulmonary Hypertension Research and Treatments (14 papers), Heart Failure Treatment and Management (11 papers) and Phosphodiesterase function and regulation (7 papers). Reshma S. Baliga is often cited by papers focused on Pulmonary Hypertension Research and Treatments (14 papers), Heart Failure Treatment and Management (11 papers) and Phosphodiesterase function and regulation (7 papers). Reshma S. Baliga collaborates with scholars based in United Kingdom, United States and Australia. Reshma S. Baliga's co-authors include John Anthony Bauer, Adrian J. Hobbs, Raymond J. MacAllister, Anne Kanderian, Hitomi Nakayama, Shengfu Piao, Cynthia A. Carnes, Tomohiro Nakayama, Patrick M. McCarthy and Mina K. Chung and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Reshma S. Baliga

28 papers receiving 1.4k citations

Peers

Reshma S. Baliga
Pablo Quintero United States
Anna Klinke Germany
Wenguang Feng United States
Peter Libby United States
Pablo Quintero United States
Reshma S. Baliga
Citations per year, relative to Reshma S. Baliga Reshma S. Baliga (= 1×) peers Pablo Quintero

Countries citing papers authored by Reshma S. Baliga

Since Specialization
Citations

This map shows the geographic impact of Reshma S. Baliga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Reshma S. Baliga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Reshma S. Baliga more than expected).

Fields of papers citing papers by Reshma S. Baliga

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Reshma S. Baliga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Reshma S. Baliga. The network helps show where Reshma S. Baliga may publish in the future.

Co-authorship network of co-authors of Reshma S. Baliga

This figure shows the co-authorship network connecting the top 25 collaborators of Reshma S. Baliga. A scholar is included among the top collaborators of Reshma S. Baliga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Reshma S. Baliga. Reshma S. Baliga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jesus, Daniel Simões de, Roberto Buccafusca, Reshma S. Baliga, et al.. (2025). Zinc-Mediated Inhibition of Soluble Epoxide Hydrolase Promotes Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 211(9). 1689–1700.
2.
Aubdool, Aisah A., Amie J. Moyes, Reshma S. Baliga, et al.. (2025). Endothelium- and Fibroblast-Derived C-Type Natriuretic Peptide Prevents the Development and Progression of Aortic Aneurysm. Arteriosclerosis Thrombosis and Vascular Biology. 45(7). 1044–1063. 1 indexed citations
3.
Papaioannou, Ioannis, Athina Dritsoula, Ping Kang, et al.. (2024). NKX2-5 regulates vessel remodeling in scleroderma-associated pulmonary arterial hypertension. JCI Insight. 9(10).
4.
Jesus, Daniel Simões de, Roberto Buccafusca, Reshma S. Baliga, et al.. (2024). Zinc-mediated inhibition of soluble epoxide hydrolase promotes pulmonary hypertension. Free Radical Biology and Medicine. 224. S58–S58. 1 indexed citations
5.
Baliga, Reshma S., Aisah A. Aubdool, Kristen J. Bubb, et al.. (2018). Phosphodiesterase 2 inhibition preferentially promotes NO/guanylyl cyclase/cGMP signaling to reverse the development of heart failure. Proceedings of the National Academy of Sciences. 115(31). E7428–E7437. 38 indexed citations
6.
Baliga, Reshma S., Raymond J. MacAllister, & Adrian J. Hobbs. (2013). Vasoactive Peptides and the Pathogenesis of Pulmonary Hypertension: Role and Potential Therapeutic Application. Handbook of experimental pharmacology. 218. 477–511. 11 indexed citations
7.
Derrett‐Smith, Emma, Audrey Dooley, A Gilbane, et al.. (2013). Endothelial Injury in a Transforming Growth Factor β–Dependent Mouse Model of Scleroderma Induces Pulmonary Arterial Hypertension. Arthritis & Rheumatism. 65(11). 2928–2939. 40 indexed citations
8.
Zhang, Tao, Xin Lü, Paul Arnold, et al.. (2011). Mitogen-activated protein kinase phosphatase-1 inhibits myocardial TNF-  expression and improves cardiac function during endotoxemia. Cardiovascular Research. 93(3). 471–479. 29 indexed citations
9.
Baliga, Reshma S., et al.. (2010). Resistance to endotoxic shock in mice lacking natriuretic peptide receptor‐A. British Journal of Pharmacology. 160(8). 2045–2054. 15 indexed citations
10.
Baliga, Reshma S., Raymond J. MacAllister, & Adrian J. Hobbs. (2010). New perspectives for the treatment of pulmonary hypertension. British Journal of Pharmacology. 163(1). 125–140. 44 indexed citations
11.
Han, Bing, Reshma S. Baliga, Hong Huang, Peter J. Giannone, & John Anthony Bauer. (2009). Decreased cardiac expression of vascular endothelial growth factor and redox imbalance in murine diabetic cardiomyopathy. American Journal of Physiology-Heart and Circulatory Physiology. 297(2). H829–H835. 43 indexed citations
12.
Baliga, Reshma S., Lan Zhao, Melanie Madhani, et al.. (2008). Synergy between Natriuretic Peptides and Phosphodiesterase 5 Inhibitors Ameliorates Pulmonary Arterial Hypertension. American Journal of Respiratory and Critical Care Medicine. 178(8). 861–869. 53 indexed citations
13.
Peiró, Concepción, et al.. (2008). Characterization of the Human α1β1 Soluble Guanylyl Cyclase Promoter. Journal of Biological Chemistry. 283(29). 20027–20036. 22 indexed citations
14.
Chaves, Alysia, Mandar Joshi, Brandon Schanbacher, et al.. (2008). Vasoprotective endothelial effects of a standardized grape product in humans. Vascular Pharmacology. 50(1-2). 20–26. 46 indexed citations
15.
Chaves, Alysia, Reshma S. Baliga, Michael J. Mihm, et al.. (2006). Bacterial Lipopolysaccharide Enhances Cardiac Dysfunction but Not Retroviral Replication in Murine AIDS. American Journal Of Pathology. 168(3). 727–736. 4 indexed citations
16.
Zhao, Qun, Xianxi Wang, Leif D. Nelin, et al.. (2005). MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock. The Journal of Experimental Medicine. 203(1). 131–140. 331 indexed citations
17.
Baliga, Reshma S., Cynthia Liu, Dale G. Hoyt, Alysia Chaves, & John Anthony Bauer. (2004). Vascular Endothelial Toxicity Induced by HIV Protease Inhibitor: Evidence of Oxidant-Related Dysfunction and Apoptosis. Cardiovascular Toxicology. 4(2). 199–206. 27 indexed citations
18.
Chaves, Alysia, Michael J. Mihm, Anupam Basuray, et al.. (2004). HIV/AIDS-Related Cardiovascular Disease. Cardiovascular Toxicology. 4(3). 229–242. 11 indexed citations
19.
Carnes, Cynthia A., Mina K. Chung, Tomohiro Nakayama, et al.. (2001). Ascorbate Attenuates Atrial Pacing-Induced Peroxynitrite Formation and Electrical Remodeling and Decreases the Incidence of Postoperative Atrial Fibrillation. Circulation Research. 89(6). E32–8. 407 indexed citations
20.
Liu, Chia‐Yang, et al.. (2000). HIV protease inhibitors promote endothelial dysfunction and oxidant formation. UCL Discovery (University College London). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026